A significant shift in Canadian drug policy has occurred, as the regulators announce the legalization of psilocybin fungi for therapeutic treatment. Previously, these substances were heavily restricted, but a growing body of evidence suggests they could offer aid for psychological illnesses like depression. The new policy represents a substantial s